Results 101 to 110 of about 21,979 (167)

Targeting Peptidergic Systems for Melanoma Treatment. [PDF]

Cancers (Basel)
Sánchez ML, Mehboob R, Coveñas R.
europepmc   +1 more source

Mechanisms involved in corticotropin-releasing factor-induced excitation of entorhinal neurons and facilitation of glutamate release at the perforant pathway. [PDF]

J Neurophysiol
Oraegbuna CS, Kurada L, Li H, Lei S.
europepmc   +1 more source

Sex-Specific Effects of Hypocretin Receptor Signaling in Corticotropin-Releasing Factor Neurons on Alcohol Drinking, Anxiety, and Extended Amygdala Neuronal Excitability. [PDF]

Biol Psychiatry Glob Open Sci
Ma Y, Sardar H, Benabou ME, Yu AC, Morningstar AR, Fajardo RN, Kandil IF, Rogers ET, Vassalli A, Kauer JA, Giardino WJ.   +10 more
europepmc   +1 more source

Targeting CRHR1 Signaling in Experimental Infantile Epileptic Spasms Syndrome: Evidence for Route-Dependent Efficacy. [PDF]

Children (Basel)
Chachua T, Yum MS, Chern CR, Vieira K, Velíšková J, Velíšek L.   +5 more
europepmc   +1 more source

Stress during the first 1,000 days of life in humans, when everything begins. [PDF]

Front Hum Neurosci
Vitalis T, Verney C.
europepmc   +1 more source

Paeoniflorin as a Promising Therapeutic Candidate in Intestinal Diseases: Experimental Evidence, Mechanistic Insights, and Translational Perspectives. [PDF]

Drug Des Devel Ther
Chang C, Xue J, Xu Z, Hou G.
europepmc   +1 more source

Engagement of the Paraventricular Nucleus of the Thalamus During Withdrawal-Related Learning: Implications for Alcohol Use Disorder. [PDF]

Biol Psychiatry Glob Open Sci
Gashi L, Khom S.
europepmc   +1 more source

Polymorphism of Melanocortin Receptor Genes-Association with Inflammatory Traits and Diseases. [PDF]

Diseases
Bardhan M, Anand A, Javed A, Chilo MA, Khan N, Garg T, Surana A, Huang H, Samim MM, Suresh V, Khare A, Menon B, Kundu T.   +12 more
europepmc   +1 more source